J.Y. Scoazec

Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

Mechanisms and disease consequences of nonalcoholic fatty liver disease

ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research

Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa